UNICHEM LABORATORIES
Back to Income Statement
|
UNICHEM LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹138 Cr | ₹-94 Cr | ₹-20,223 Cr | ₹33 Cr | ₹34 Cr |
What is the latest Consolidated Net Profit of UNICHEM LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹138 Cr |
| Mar2025 | ₹-94 Cr |
| Mar2024 | ₹-20,223 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹34 Cr |
How is Consolidated Net Profit of UNICHEM LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹138 Cr | Positive | |
| Mar2025 | ₹-94 Cr | Negative | |
| Mar2024 | ₹-20,223 Cr | Negative | |
| Mar2023 | ₹33 Cr | -3.68 | |
| Mar2022 | ₹34 Cr | - | |
Compare Consolidated Net Profit of peers of UNICHEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| UNICHEM LABORATORIES | ₹3,332.0 Cr | 4.4% | 27% | -22.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
UNICHEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | 4.4% |
27% |
-22.5% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses